Table S3 from IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance Article Swipe

View

Zoë Johnson , Chiara Tarantelli , Elisa Civanelli , Luciano Cascione , Filippo Spriano , Amy Fraser , Pritom Shah , Tyzoon Nomanbhoy , Sara Napoli , Andrea Rinaldi , Karolina Niewola‐Staszkowska , Michael Lahn , Dominique Perrin , Mathias Wenes , Denis Migliorini , Francesco Bertoni , Lars van der Veen , Giusy Di Conza ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/2767-9764.22634419.v1

Table showing the raw data of the AUC value of figure 2A

Related Topics

Concepts

Table (database) Value (mathematics) Immune system PI3K/AKT/mTOR pathway Chemistry Cancer research Biology Database Biochemistry Computer science Mathematics Immunology Statistics Signal transduction

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/2767-9764.22634419.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4376171490

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4376171490

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/2767-9764.22634419.v1

Digital Object Identifier
Title: Table S3 from IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-04-14

Full publication date if available
Authors: Zoë Johnson, Chiara Tarantelli, Elisa Civanelli, Luciano Cascione, Filippo Spriano, Amy Fraser, Pritom Shah, Tyzoon Nomanbhoy, Sara Napoli, Andrea Rinaldi, Karolina Niewola‐Staszkowska, Michael Lahn, Dominique Perrin, Mathias Wenes, Denis Migliorini, Francesco Bertoni, Lars van der Veen, Giusy Di Conza

List of authors in order
Landing page: https://doi.org/10.1158/2767-9764.22634419.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/2767-9764.22634419.v1

Direct OA link when available
Concepts: Table (database), Value (mathematics), Immune system, PI3K/AKT/mTOR pathway, Chemistry, Cancer research, Biology, Database, Biochemistry, Computer science, Mathematics, Immunology, Statistics, Signal transduction

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4376171490
doi	https://doi.org/10.1158/2767-9764.22634419.v1
ids.doi	https://doi.org/10.1158/2767-9764.22634419.v1
ids.openalex	https://openalex.org/W4376171490
fwci	0.0
type	preprint
title	Table S3 from IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10417
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.8804000020027161
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2740
topics[0].subfield.display_name	Pulmonary and Respiratory Medicine
topics[0].display_name	Lung Cancer Treatments and Mutations
topics[1].id	https://openalex.org/T10231
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.8628000020980835
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Pancreatic and Hepatic Oncology Research
topics[2].id	https://openalex.org/T12829
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.7864999771118164
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2740
topics[2].subfield.display_name	Pulmonary and Respiratory Medicine
topics[2].display_name	Advanced Breast Cancer Therapies
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C45235069
concepts[0].level	2
concepts[0].score	0.7912425994873047
concepts[0].wikidata	https://www.wikidata.org/wiki/Q278425
concepts[0].display_name	Table (database)
concepts[1].id	https://openalex.org/C2776291640
concepts[1].level	2
concepts[1].score	0.6052819490432739
concepts[1].wikidata	https://www.wikidata.org/wiki/Q2912517
concepts[1].display_name	Value (mathematics)
concepts[2].id	https://openalex.org/C8891405
concepts[2].level	2
concepts[2].score	0.5157418847084045
concepts[2].wikidata	https://www.wikidata.org/wiki/Q1059
concepts[2].display_name	Immune system
concepts[3].id	https://openalex.org/C86554907
concepts[3].level	3
concepts[3].score	0.4677004814147949
concepts[3].wikidata	https://www.wikidata.org/wiki/Q285613
concepts[3].display_name	PI3K/AKT/mTOR pathway
concepts[4].id	https://openalex.org/C185592680
concepts[4].level	0
concepts[4].score	0.3537898361682892
concepts[4].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[4].display_name	Chemistry
concepts[5].id	https://openalex.org/C502942594
concepts[5].level	1
concepts[5].score	0.3476080596446991
concepts[5].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[5].display_name	Cancer research
concepts[6].id	https://openalex.org/C86803240
concepts[6].level	0
concepts[6].score	0.3017929196357727
concepts[6].wikidata	https://www.wikidata.org/wiki/Q420
concepts[6].display_name	Biology
concepts[7].id	https://openalex.org/C77088390
concepts[7].level	1
concepts[7].score	0.27835410833358765
concepts[7].wikidata	https://www.wikidata.org/wiki/Q8513
concepts[7].display_name	Database
concepts[8].id	https://openalex.org/C55493867
concepts[8].level	1
concepts[8].score	0.2387603521347046
concepts[8].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[8].display_name	Biochemistry
concepts[9].id	https://openalex.org/C41008148
concepts[9].level	0
concepts[9].score	0.2361733615398407
concepts[9].wikidata	https://www.wikidata.org/wiki/Q21198
concepts[9].display_name	Computer science
concepts[10].id	https://openalex.org/C33923547
concepts[10].level	0
concepts[10].score	0.2305988073348999
concepts[10].wikidata	https://www.wikidata.org/wiki/Q395
concepts[10].display_name	Mathematics
concepts[11].id	https://openalex.org/C203014093
concepts[11].level	1
concepts[11].score	0.21443060040473938
concepts[11].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[11].display_name	Immunology
concepts[12].id	https://openalex.org/C105795698
concepts[12].level	1
concepts[12].score	0.12559476494789124
concepts[12].wikidata	https://www.wikidata.org/wiki/Q12483
concepts[12].display_name	Statistics
concepts[13].id	https://openalex.org/C62478195
concepts[13].level	2
concepts[13].score	0.11949217319488525
concepts[13].wikidata	https://www.wikidata.org/wiki/Q828130
concepts[13].display_name	Signal transduction
keywords[0].id	https://openalex.org/keywords/table
keywords[0].score	0.7912425994873047
keywords[0].display_name	Table (database)
keywords[1].id	https://openalex.org/keywords/value
keywords[1].score	0.6052819490432739
keywords[1].display_name	Value (mathematics)
keywords[2].id	https://openalex.org/keywords/immune-system
keywords[2].score	0.5157418847084045
keywords[2].display_name	Immune system
keywords[3].id	https://openalex.org/keywords/pi3k/akt/mtor-pathway
keywords[3].score	0.4677004814147949
keywords[3].display_name	PI3K/AKT/mTOR pathway
keywords[4].id	https://openalex.org/keywords/chemistry
keywords[4].score	0.3537898361682892
keywords[4].display_name	Chemistry
keywords[5].id	https://openalex.org/keywords/cancer-research
keywords[5].score	0.3476080596446991
keywords[5].display_name	Cancer research
keywords[6].id	https://openalex.org/keywords/biology
keywords[6].score	0.3017929196357727
keywords[6].display_name	Biology
keywords[7].id	https://openalex.org/keywords/database
keywords[7].score	0.27835410833358765
keywords[7].display_name	Database
keywords[8].id	https://openalex.org/keywords/biochemistry
keywords[8].score	0.2387603521347046
keywords[8].display_name	Biochemistry
keywords[9].id	https://openalex.org/keywords/computer-science
keywords[9].score	0.2361733615398407
keywords[9].display_name	Computer science
keywords[10].id	https://openalex.org/keywords/mathematics
keywords[10].score	0.2305988073348999
keywords[10].display_name	Mathematics
keywords[11].id	https://openalex.org/keywords/immunology
keywords[11].score	0.21443060040473938
keywords[11].display_name	Immunology
keywords[12].id	https://openalex.org/keywords/statistics
keywords[12].score	0.12559476494789124
keywords[12].display_name	Statistics
keywords[13].id	https://openalex.org/keywords/signal-transduction
keywords[13].score	0.11949217319488525
keywords[13].display_name	Signal transduction
language	en
locations[0].id	doi:10.1158/2767-9764.22634419.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/2767-9764.22634419.v1
locations[1].id	pmh:oai:figshare.com:article/22634419
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Table_S3_from_IOA-244_is_a_Non_ATP-competitive_Highly_Selective_Tolerable_PI3K_Delta_Inhibitor_That_Targets_Solid_Tumors_and_Breaks_Immune_Tolerance/22634419
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5076391983
authorships[0].author.orcid	https://orcid.org/0000-0002-4120-2579
authorships[0].author.display_name	Zoë Johnson
authorships[0].author_position	first
authorships[0].raw_author_name	Zoë Johnson
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5064713685
authorships[1].author.orcid	https://orcid.org/0000-0002-4394-7742
authorships[1].author.display_name	Chiara Tarantelli
authorships[1].author_position	middle
authorships[1].raw_author_name	Chiara Tarantelli
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5037565739
authorships[2].author.orcid	https://orcid.org/0000-0001-5427-8372
authorships[2].author.display_name	Elisa Civanelli
authorships[2].author_position	middle
authorships[2].raw_author_name	Elisa Civanelli
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5012537023
authorships[3].author.orcid	https://orcid.org/0000-0002-4606-0637
authorships[3].author.display_name	Luciano Cascione
authorships[3].author_position	middle
authorships[3].raw_author_name	Luciano Cascione
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5038420682
authorships[4].author.orcid	https://orcid.org/0000-0002-8615-1568
authorships[4].author.display_name	Filippo Spriano
authorships[4].author_position	middle
authorships[4].raw_author_name	Filippo Spriano
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5082767891
authorships[5].author.orcid	https://orcid.org/0009-0007-4883-7538
authorships[5].author.display_name	Amy Fraser
authorships[5].author_position	middle
authorships[5].raw_author_name	Amy Fraser
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5000443005
authorships[6].author.orcid	https://orcid.org/0009-0001-7381-4609
authorships[6].author.display_name	Pritom Shah
authorships[6].author_position	middle
authorships[6].raw_author_name	Pritom Shah
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5026430839
authorships[7].author.orcid	https://orcid.org/0000-0003-3514-8542
authorships[7].author.display_name	Tyzoon Nomanbhoy
authorships[7].author_position	middle
authorships[7].raw_author_name	Tyzoon Nomanbhoy
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5073945848
authorships[8].author.orcid	https://orcid.org/0000-0002-9699-7540
authorships[8].author.display_name	Sara Napoli
authorships[8].author_position	middle
authorships[8].raw_author_name	Sara Napoli
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5039188583
authorships[9].author.orcid	https://orcid.org/0000-0003-3234-0563
authorships[9].author.display_name	Andrea Rinaldi
authorships[9].author_position	middle
authorships[9].raw_author_name	Andrea Rinaldi
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5073306162
authorships[10].author.orcid	https://orcid.org/0000-0001-7225-3419
authorships[10].author.display_name	Karolina Niewola‐Staszkowska
authorships[10].author_position	middle
authorships[10].raw_author_name	Karolina Niewola-Staszkowska
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5033549340
authorships[11].author.orcid	https://orcid.org/0000-0002-1377-7308
authorships[11].author.display_name	Michael Lahn
authorships[11].author_position	middle
authorships[11].raw_author_name	Michael Lahn
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5023891526
authorships[12].author.orcid	https://orcid.org/0000-0003-1290-1888
authorships[12].author.display_name	Dominique Perrin
authorships[12].author_position	middle
authorships[12].raw_author_name	Dominique Perrin
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5053744258
authorships[13].author.orcid	https://orcid.org/0000-0001-8478-8592
authorships[13].author.display_name	Mathias Wenes
authorships[13].author_position	middle
authorships[13].raw_author_name	Mathias Wenes
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5089193809
authorships[14].author.orcid	https://orcid.org/0000-0003-0151-3222
authorships[14].author.display_name	Denis Migliorini
authorships[14].author_position	middle
authorships[14].raw_author_name	Denis Migliorini
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5066518317
authorships[15].author.orcid	https://orcid.org/0000-0001-5637-8983
authorships[15].author.display_name	Francesco Bertoni
authorships[15].author_position	middle
authorships[15].raw_author_name	Francesco Bertoni
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5091158700
authorships[16].author.orcid	https://orcid.org/0000-0003-4525-0081
authorships[16].author.display_name	Lars van der Veen
authorships[16].author_position	middle
authorships[16].raw_author_name	Lars van der Veen
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5042790504
authorships[17].author.orcid	https://orcid.org/0000-0003-1353-5867
authorships[17].author.display_name	Giusy Di Conza
authorships[17].author_position	last
authorships[17].raw_author_name	Giusy Di Conza
authorships[17].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/2767-9764.22634419.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Table S3 from IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10417
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.8804000020027161
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2740
primary_topic.subfield.display_name	Pulmonary and Respiratory Medicine
primary_topic.display_name	Lung Cancer Treatments and Mutations
related_works	https://openalex.org/W1006589974, https://openalex.org/W1974250949, https://openalex.org/W2031281657, https://openalex.org/W1978608178, https://openalex.org/W2011424260, https://openalex.org/W155856152, https://openalex.org/W2898511335, https://openalex.org/W3188367623, https://openalex.org/W4220837694, https://openalex.org/W2515075097
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/2767-9764.22634419.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/2767-9764.22634419.v1
primary_location.id	doi:10.1158/2767-9764.22634419.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/2767-9764.22634419.v1
publication_date	2023-04-14
publication_year	2023
referenced_works_count	0
abstract_inverted_index.of	5, 9
abstract_inverted_index.AUC	7
abstract_inverted_index.raw	3
abstract_inverted_index.the	2, 6
abstract_inverted_index.data	4
abstract_inverted_index.value	8
abstract_inverted_index.figure	10
abstract_inverted_index.showing	1
abstract_inverted_index.2A</p>	11
abstract_inverted_index.<p>Table	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	18
citation_normalized_percentile.value	0.23953561
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False